Publications by Viola Nähse-Kumpf

5 publications found

Publications 2015

1. Magnussen GI, Emilsen E, Giller Fleten K, Engesæter B, Nähse-Kumpf V, Fjær R, Slipicevic A, Flørenes VA (2015)
   Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma
   BMC Cancer, 15, 462
   DOI 10.1186/s12885-015-1474-8, PubMed 26054341

Publications 2014

1. Lund-Andersen C, Patzke S, Nähse-Kumpf V, Syljuåsen RG (2014)
   PLK1-inhibition can cause radiosensitization or radioresistance dependent on the treatment schedule
   Radiother Oncol, 110 (2), 355-61
   DOI 10.1016/j.radonc.2013.12.014, PubMed 24502970

Publications 2013

1. Hasvold G, Nähse-Kumpf V, Tkacz-Stachowska K, Rofstad EK, Syljuåsen RG (2013)
   The efficacy of CHK1 inhibitors is not altered by hypoxia, but is enhanced after reoxygenation
   Mol Cancer Ther, 12 (5), 705-16
   DOI 10.1158/1535-7163.MCT-12-0879, PubMed 23635654

Publications 2012

1. Beck H, Nähse-Kumpf V, Larsen MS, O'Hanlon KA, Patzke S, Holmberg C, Mejlvang J, Groth A, Nielsen O, Syljuåsen RG, Sørensen CS (2012)
   Cyclin-dependent kinase suppression by WEE1 kinase protects the genome through control of replication initiation and nucleotide consumption
   Mol Cell Biol, 32 (20), 4226-36
   DOI 10.1128/MCB.00412-12, PubMed 22907750

Publications 2011

1. Menzel T, Nähse-Kumpf V, Kousholt AN, Klein DK, Lund-Andersen C, Lees M, Johansen JV, Syljuåsen RG, Sørensen CS (2011)
   A genetic screen identifies BRCA2 and PALB2 as key regulators of G2 checkpoint maintenance
   EMBO Rep, 12 (7), 705-12
   DOI 10.1038/embor.2011.99, PubMed 21637299